drugset / Trial / NCT05043675
Clinical Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients
NaSingle-groupOpen-labelOther
Summary
The overall objective of this study is to evaluate the overall pattern of \[18F\]APN-1607 uptake in subjects with AD dementia
Timeline
- Start
- 2021-09-10
- Primary completion
- 2024-09-10
- Completion
- 2024-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]APN-1607 | Diagnostic / imaging agent | 3.7 mbq/kg | Other |
| Subject | [18F]APN-1607 | Diagnostic / imaging agent | 5.55 mbq/kg | Other |